Ramorelix
Ramorelix is a luteinizing-hormone-releasing hormone (LHRH) antagonist. Ramorelix can inhibit tumor progression in vivo. Ramorelix can be studied in anti-cancer research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 127932-90-5
- Formel: C74H95ClN16O18
- Molecular Weight:1532.10
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Chemical Information
-
CAS. Nr. 127932-90-5
-
Molecular Weight 1532.10
-
Formel C74H95ClN16O18
-
Sequence
{d-Ala(N-acetyl-3-(2-naphthalenyl))}-{d-Phe(Cl)}-{d-Trp}-Ser-Tyr-{d-Ser(2-(aminocarbonyl)hydrazide)}-Leu-Arg-Pro
-
Sequence Shortening
{d-Ala(N-acetyl-3-(2-naphthalenyl))}-{d-Phe(Cl)}-{d-Trp}-SY-{d-Ser(2-(aminocarbonyl)hydrazide)}-LRP
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Stoeckemann, K., & Sandow, J. (1993). Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations. Journal of cancer research and clinical oncology, 119(8), 457-462. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)